| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | supraspliceosomal complex | 5.69e-05 | 4 | 65 | 2 | GO:0044530 | |
| GeneOntologyCellularComponent | microtubule minus-end | 1.98e-04 | 7 | 65 | 2 | GO:0036449 | |
| Domain | IMD | 1.04e-04 | 5 | 61 | 2 | PS51338 | |
| Domain | IMD | 1.56e-04 | 6 | 61 | 2 | PF08397 | |
| Domain | RBM1CTR | 2.90e-04 | 8 | 61 | 2 | PF08081 | |
| Domain | RBM1CTR | 2.90e-04 | 8 | 61 | 2 | IPR012604 | |
| Domain | I-BAR_dom | 8.00e-04 | 13 | 61 | 2 | IPR013606 | |
| Domain | RRM_dom_euk | 2.54e-03 | 23 | 61 | 2 | IPR003954 | |
| Domain | RRM_1 | 2.54e-03 | 23 | 61 | 2 | SM00361 | |
| Domain | HECT | 3.49e-03 | 27 | 61 | 2 | PF00632 | |
| Domain | HECTc | 3.49e-03 | 27 | 61 | 2 | SM00119 | |
| Domain | HECT_dom | 3.49e-03 | 27 | 61 | 2 | IPR000569 | |
| Domain | HECT | 3.49e-03 | 27 | 61 | 2 | PS50237 | |
| Domain | DEAD_ATP_HELICASE | 4.59e-03 | 31 | 61 | 2 | PS00039 | |
| Domain | RNA-helicase_DEAD-box_CS | 5.19e-03 | 33 | 61 | 2 | IPR000629 | |
| Domain | Q_MOTIF | 6.49e-03 | 37 | 61 | 2 | PS51195 | |
| Domain | RNA_helicase_DEAD_Q_motif | 6.49e-03 | 37 | 61 | 2 | IPR014014 | |
| Pubmed | 6.25e-07 | 263 | 65 | 7 | 34702444 | ||
| Pubmed | 9.26e-07 | 407 | 65 | 8 | 12693553 | ||
| Pubmed | ALMS1 TTC28 L3MBTL2 AGFG1 PUM2 PEX13 TMEM131 DDX20 XRCC1 MGA | 1.02e-06 | 733 | 65 | 10 | 34672954 | |
| Pubmed | 4.12e-06 | 225 | 65 | 6 | 12168954 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 4.29e-06 | 861 | 65 | 10 | 36931259 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 1.00e-05 | 949 | 65 | 10 | 36574265 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 34458856 | ||
| Pubmed | RBMX is a novel hepatic transcriptional regulator of SREBP-1c gene response to high-fructose diet. | 1.03e-05 | 3 | 65 | 2 | 17188681 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 21800163 | ||
| Pubmed | RBMY evolved on the Y chromosome from a ubiquitously transcribed X-Y identical gene. | 1.03e-05 | 3 | 65 | 2 | 10391207 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 38733337 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 34638419 | ||
| Pubmed | 1.14e-05 | 963 | 65 | 10 | 28671696 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.58e-05 | 430 | 65 | 7 | 35044719 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | ALMS1 TTC28 RBMXL1 CDK13 RBMX FGA PUM2 PEX13 TMEM131 DDX20 EMD SUCO | 1.87e-05 | 1496 | 65 | 12 | 32877691 |
| Pubmed | Transcriptional regulation of the Alström syndrome gene ALMS1 by members of the RFX family and Sp1. | 2.06e-05 | 4 | 65 | 2 | 20381594 | |
| Pubmed | SAFB1, an RBMX-binding protein, is a newly identified regulator of hepatic SREBP-1c gene. | 2.06e-05 | 4 | 65 | 2 | 19403048 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 2.51e-05 | 184 | 65 | 5 | 32908313 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 2.68e-05 | 313 | 65 | 6 | 38270169 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 2.88e-05 | 853 | 65 | 9 | 28718761 | |
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 20093484 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 28425671 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 17696464 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 21360055 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 4.02e-05 | 498 | 65 | 7 | 36634849 | |
| Pubmed | Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. | 5.43e-05 | 39 | 65 | 3 | 19010793 | |
| Pubmed | 6.13e-05 | 222 | 65 | 5 | 35941108 | ||
| Pubmed | 7.18e-05 | 7 | 65 | 2 | 10075840 | ||
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 7.39e-05 | 231 | 65 | 5 | 16452087 | |
| Pubmed | 7.59e-05 | 551 | 65 | 7 | 34728620 | ||
| Pubmed | A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. | 9.09e-05 | 125 | 65 | 4 | 21654808 | |
| Pubmed | 9.56e-05 | 8 | 65 | 2 | 21041365 | ||
| Pubmed | CIP2A Interacts with TopBP1 and Drives Basal-Like Breast Cancer Tumorigenesis. | 9.56e-05 | 8 | 65 | 2 | 34145035 | |
| Pubmed | 9.56e-05 | 8 | 65 | 2 | 27899448 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 9.57e-05 | 774 | 65 | 8 | 15302935 | |
| Pubmed | 1.08e-04 | 49 | 65 | 3 | 31762063 | ||
| Pubmed | 1.17e-04 | 591 | 65 | 7 | 15231748 | ||
| Pubmed | 1.23e-04 | 9 | 65 | 2 | 21358275 | ||
| Pubmed | Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation. | 1.24e-04 | 258 | 65 | 5 | 21081666 | |
| Pubmed | 1.32e-04 | 418 | 65 | 6 | 34709266 | ||
| Pubmed | 1.53e-04 | 10 | 65 | 2 | 32814086 | ||
| Pubmed | U box proteins as a new family of ubiquitin-protein ligases. | 1.53e-04 | 10 | 65 | 2 | 11435423 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 1.85e-04 | 281 | 65 | 5 | 28706196 | |
| Pubmed | Variants in LRRC7 lead to intellectual disability, autism, aggression and abnormal eating behaviors. | 1.87e-04 | 11 | 65 | 2 | 39256359 | |
| Pubmed | 1.87e-04 | 11 | 65 | 2 | 21191027 | ||
| Pubmed | 1.87e-04 | 11 | 65 | 2 | 35933409 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 1.92e-04 | 857 | 65 | 8 | 25609649 | |
| Pubmed | 2.14e-04 | 652 | 65 | 7 | 31180492 | ||
| Pubmed | 2.24e-04 | 657 | 65 | 7 | 36180527 | ||
| Pubmed | 2.24e-04 | 12 | 65 | 2 | 35970860 | ||
| Pubmed | Replication of top markers of a genome-wide association study in multiple sclerosis in Spain. | 2.24e-04 | 12 | 65 | 2 | 20944657 | |
| Pubmed | 2.24e-04 | 12 | 65 | 2 | 19149558 | ||
| Pubmed | 2.46e-04 | 162 | 65 | 4 | 25796446 | ||
| Pubmed | 2.51e-04 | 65 | 65 | 3 | 22496869 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 2.52e-04 | 670 | 65 | 7 | 22990118 | |
| Pubmed | 2.65e-04 | 13 | 65 | 2 | 32909945 | ||
| Pubmed | TRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson's disease. | 2.74e-04 | 67 | 65 | 3 | 34644545 | |
| Pubmed | 2.74e-04 | 67 | 65 | 3 | 29254152 | ||
| Pubmed | 3.03e-04 | 1429 | 65 | 10 | 35140242 | ||
| Pubmed | 3.08e-04 | 14 | 65 | 2 | 27184118 | ||
| Pubmed | 3.20e-04 | 493 | 65 | 6 | 15368895 | ||
| Pubmed | 3.45e-04 | 177 | 65 | 4 | 26206133 | ||
| Pubmed | 3.56e-04 | 15 | 65 | 2 | 23236378 | ||
| Pubmed | 3.56e-04 | 15 | 65 | 2 | 28784777 | ||
| Pubmed | 3.56e-04 | 15 | 65 | 2 | 22513377 | ||
| Pubmed | 3.57e-04 | 503 | 65 | 6 | 36217030 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 3.94e-04 | 954 | 65 | 8 | 36373674 | |
| Pubmed | 3.97e-04 | 76 | 65 | 3 | 27542412 | ||
| Pubmed | 4.59e-04 | 17 | 65 | 2 | 34622152 | ||
| Pubmed | 4.59e-04 | 17 | 65 | 2 | 37072811 | ||
| Pubmed | MEF2C transcription factor controls chondrocyte hypertrophy and bone development. | 4.59e-04 | 17 | 65 | 2 | 17336904 | |
| Pubmed | 4.62e-04 | 80 | 65 | 3 | 35803934 | ||
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 4.99e-04 | 349 | 65 | 5 | 25665578 | |
| Pubmed | 5.14e-04 | 83 | 65 | 3 | 9039502 | ||
| Pubmed | 5.16e-04 | 18 | 65 | 2 | 19961560 | ||
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | 5.25e-04 | 353 | 65 | 5 | 27545878 | |
| Pubmed | Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes. | 5.33e-04 | 84 | 65 | 3 | 15203218 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 6.28e-04 | 1024 | 65 | 8 | 24711643 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 6.57e-04 | 565 | 65 | 6 | 25468996 | |
| Pubmed | An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. | 6.73e-04 | 91 | 65 | 3 | 20362542 | |
| Pubmed | 7.06e-04 | 21 | 65 | 2 | 27600842 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 7.73e-04 | 583 | 65 | 6 | 29844126 | |
| Pubmed | 7.76e-04 | 22 | 65 | 2 | 24301466 | ||
| Pubmed | BDNF and NT4 play interchangeable roles in gustatory development. | 8.48e-04 | 23 | 65 | 2 | 24378336 | |
| Pubmed | 8.48e-04 | 23 | 65 | 2 | 26027930 | ||
| Pubmed | 8.62e-04 | 226 | 65 | 4 | 31452512 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 9.60e-04 | 608 | 65 | 6 | 36089195 | |
| Pubmed | 1.00e-03 | 25 | 65 | 2 | 23873930 | ||
| Pubmed | 1.00e-03 | 25 | 65 | 2 | 15229182 | ||
| Pubmed | AP-2δ is a crucial transcriptional regulator of the posterior midbrain. | 1.00e-03 | 25 | 65 | 2 | 21858141 | |
| Pubmed | 1.01e-03 | 408 | 65 | 5 | 33766124 | ||
| Pubmed | System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes. | 1.09e-03 | 26 | 65 | 2 | 26949039 | |
| Pubmed | Interactome of the negative regulator of nuclear import BRCA1-binding protein 2. | 1.09e-03 | 26 | 65 | 2 | 25820252 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 1.12e-03 | 626 | 65 | 6 | 33644029 | |
| Pubmed | 1.14e-03 | 109 | 65 | 3 | 29511296 | ||
| Pubmed | 1.14e-03 | 244 | 65 | 4 | 29884807 | ||
| Pubmed | 1.16e-03 | 245 | 65 | 4 | 21182205 | ||
| Pubmed | 1.23e-03 | 112 | 65 | 3 | 28416769 | ||
| Pubmed | 1.27e-03 | 430 | 65 | 5 | 32581705 | ||
| Pubmed | 1.36e-03 | 116 | 65 | 3 | 21549307 | ||
| Interaction | BTRC interactions | CSF1R ALMS1 BCL2L11 PHF19 UBE4B RBMX PHLPP1 EMD XRCC1 PLK4 DDX3X NEDD4 | 2.96e-06 | 775 | 61 | 12 | int:BTRC |
| Interaction | FBXW11 interactions | 1.18e-05 | 473 | 61 | 9 | int:FBXW11 | |
| Interaction | PAIP2 interactions | 3.96e-05 | 63 | 61 | 4 | int:PAIP2 | |
| Interaction | RNF43 interactions | 4.19e-05 | 427 | 61 | 8 | int:RNF43 | |
| Interaction | TRIM52 interactions | 5.13e-05 | 133 | 61 | 5 | int:TRIM52 | |
| Interaction | LATS1 interactions | 5.18e-05 | 440 | 61 | 8 | int:LATS1 | |
| Interaction | POU5F1 interactions | 6.13e-05 | 584 | 61 | 9 | int:POU5F1 | |
| Interaction | CNOT9 interactions | 6.97e-05 | 231 | 61 | 6 | int:CNOT9 | |
| Interaction | CHAMP1 interactions | 8.53e-05 | 148 | 61 | 5 | int:CHAMP1 | |
| Interaction | LITAF interactions | 8.71e-05 | 77 | 61 | 4 | int:LITAF | |
| Cytoband | 4q28 | 7.06e-05 | 9 | 65 | 2 | 4q28 | |
| GeneFamily | I-BAR domain containing | 6.58e-05 | 5 | 47 | 2 | 1287 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_UP | 3.70e-07 | 184 | 65 | 7 | M9988 | |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_UP | 7.53e-06 | 189 | 65 | 6 | M9978 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | SP4 BCL2L11 UBE4B UBR5 CDK13 NUMA1 PUM2 PEX13 TMEM131 ZBTB18 PLK4 MEF2C | 3.85e-05 | 1215 | 65 | 12 | M41122 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | TTC28 UBR5 CDK13 AGFG1 PHLPP1 PUM2 TMEM131 SUCO ZBTB18 NEDD4 | 4.61e-05 | 856 | 65 | 10 | M4500 |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.52e-07 | 190 | 65 | 6 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-Immature_CPNs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.48e-07 | 198 | 65 | 6 | 4e598aab92141e7d32ec963291ddeed14a21beba | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 4.75e-07 | 200 | 65 | 6 | e4f0bb57be1112869c7068d0a789c2b802a442dd | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.75e-06 | 175 | 65 | 5 | 15c69dd5635c9251c535f1e22467712e9667ae92 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-06 | 185 | 65 | 5 | 742350093d90f96735dc73e3360cdd749bae63fd | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.73e-06 | 186 | 65 | 5 | 2e024097ee361eeb1d855a4edb8ac8cdad35da06 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.73e-06 | 186 | 65 | 5 | c3449e54454009973818fc1101933c6f0168258c | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D175|Adult / Lineage, Cell type, age group and donor | 7.93e-06 | 187 | 65 | 5 | f3548817f2fded5978137bb252cb628ac199e4f6 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class | 8.79e-06 | 191 | 65 | 5 | 322237793a1278bafb14e63cab688b353e352dcc | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.01e-06 | 192 | 65 | 5 | 52acaecd3703166f5ce3b328aff7c82bd142fee4 | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 9.24e-06 | 193 | 65 | 5 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.96e-06 | 196 | 65 | 5 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-CPNs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.96e-06 | 196 | 65 | 5 | c9e7ac34993c873de4f198cdae77dcf099731532 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-05 | 197 | 65 | 5 | 15d1e0dffee8f5ba8cee37adfbfa0551a0cd5e15 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-05 | 198 | 65 | 5 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-05 | 198 | 65 | 5 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Bronchus_Control_(B.)-Endothelial-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.05e-05 | 198 | 65 | 5 | feac39036b5c0ab97b524cc366286942d136d42f | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.05e-05 | 198 | 65 | 5 | a0032e3ed259e39324a659490b9d340c5d9ba0fc | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-05 | 198 | 65 | 5 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Bronchus_Control_(B.)-Endothelial-TX-Bronchial_vessel|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.05e-05 | 198 | 65 | 5 | dcf334d13e5b0018fee24febccfef91c9e17843b | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.07e-05 | 199 | 65 | 5 | 0cd3e4e0fba000c996feaf012ff32198e1048c9d | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-05 | 200 | 65 | 5 | a8b59e6fe04271fef61db911a286b5c48438bb84 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.10e-05 | 200 | 65 | 5 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Cortical_neuron|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.10e-05 | 200 | 65 | 5 | c248233b004f8ef0bab3c65ecfe295887966f2ee | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal|3m / Sample Type, Dataset, Time_group, and Cell type. | 1.10e-05 | 200 | 65 | 5 | af99d90070e2933fd2e9512590c6cf3bd6e15539 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-CPNs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.10e-05 | 200 | 65 | 5 | 71cbefbef4ae5bbb5f6e419914f4b3b3b5a5f9e3 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-3|TCGA-Skin / Sample_Type by Project: Shred V9 | 8.60e-05 | 159 | 65 | 4 | fb222c42f66901852b01cec073ec0732245ee973 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Tox|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.13e-04 | 64 | 65 | 3 | bf923a66b17e717b8d3817b9d0e201b82a7e4a88 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Tox-Inhibitory_Gad1Gad2_Cplx3.Tox_(Interneuron,_lacunosum_oriens1?)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.13e-04 | 64 | 65 | 3 | a3e852600c53b11175eb579e92962fa711f5678b | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Tox-Inhibitory_Gad1Gad2_Cplx3.Tox_(Interneuron,_lacunosum_oriens1?)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.13e-04 | 64 | 65 | 3 | f8f43ad9354c786b418bac54614f96f50e8bea68 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.16e-04 | 172 | 65 | 4 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.36e-04 | 179 | 65 | 4 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | metastatic_Brain-Endothelial_cells-Lymphatic_ECs|metastatic_Brain / Location, Cell class and cell subclass | 1.36e-04 | 179 | 65 | 4 | 56fe381ffbaba3a4f2f587a3e367b0d11fbd4a2a | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 1.42e-04 | 181 | 65 | 4 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.42e-04 | 181 | 65 | 4 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175|Adult / Lineage, Cell type, age group and donor | 1.45e-04 | 182 | 65 | 4 | 8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.45e-04 | 182 | 65 | 4 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.48e-04 | 183 | 65 | 4 | ce8be9418b473ea94ec806edc7a2078cc30c1703 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.54e-04 | 185 | 65 | 4 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-04 | 185 | 65 | 4 | 808d5e880069aff8866cd2c733b9fe568a37701f | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 1.54e-04 | 185 | 65 | 4 | 4abe04198ab5047c211f8d09cdb9650fa52a3cd6 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|COPD / Disease state, Lineage and Cell class | 1.57e-04 | 186 | 65 | 4 | 23c7d0e8372a71546d687278b985f761d282f92f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 186 | 65 | 4 | a1ab273b01971d6a892912560d387685dd657179 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.57e-04 | 186 | 65 | 4 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.60e-04 | 187 | 65 | 4 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 187 | 65 | 4 | ef3c85c01bc3da408ae288b6e3096ad888a12e63 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Control / Disease state, Lineage and Cell class | 1.60e-04 | 187 | 65 | 4 | 54d7588172ac145ff5045ad9771636729ca3f0ca | |
| ToppCell | Control-Endothelial-VE_Peribronchial|Control / Disease state, Lineage and Cell class | 1.64e-04 | 188 | 65 | 4 | f5b7dbc89f992c13280d36a34935be83906b1bc0 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.67e-04 | 189 | 65 | 4 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.67e-04 | 189 | 65 | 4 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 1.71e-04 | 190 | 65 | 4 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 190 | 65 | 4 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.71e-04 | 190 | 65 | 4 | 8d6ef93d69e96cd6921816d152bea3b0710cf147 | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.71e-04 | 190 | 65 | 4 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | Endothelial-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.74e-04 | 191 | 65 | 4 | f702dfe88a9b04091dae87df61b2b4f43525f86a | |
| ToppCell | Control-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 1.74e-04 | 191 | 65 | 4 | c672c8e28d06d555335976b3f8bd2ea6d3b34aae | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.74e-04 | 191 | 65 | 4 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.78e-04 | 192 | 65 | 4 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.78e-04 | 192 | 65 | 4 | e09f609fed033a25baacaf4a07bbbae1076da366 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 1.78e-04 | 192 | 65 | 4 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-04 | 192 | 65 | 4 | 3e1a4cb0d83efd502c8613d41a1692bdda5860ed | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.81e-04 | 193 | 65 | 4 | f582e939e3e08a8a3f71deec78c33715be8faa51 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.81e-04 | 193 | 65 | 4 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 193 | 65 | 4 | 826b8dd801298b3e0cd76232feae5a14026b8806 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 1.81e-04 | 193 | 65 | 4 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-04 | 193 | 65 | 4 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 193 | 65 | 4 | 87d3a577d37fb0cb4b6313c596310de452bc3872 | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 1.81e-04 | 193 | 65 | 4 | d7750a7575ef257963b7f1c64fa67c52dbff797b | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.81e-04 | 193 | 65 | 4 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.81e-04 | 193 | 65 | 4 | ad2df9b77999780860141be6ec366afc0172a331 | |
| ToppCell | COPD-Endothelial|COPD / Disease state, Lineage and Cell class | 1.81e-04 | 193 | 65 | 4 | 093b28dcccb5841c995d0b33fae0efd6b88f97e0 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 193 | 65 | 4 | d485634c564b268e344b6a2863c26f6adaec9e38 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.81e-04 | 193 | 65 | 4 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.81e-04 | 193 | 65 | 4 | ad3f4fcc8e2816d696cbcde744dc16500e51ccac | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.85e-04 | 194 | 65 | 4 | 71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-04 | 194 | 65 | 4 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 1.85e-04 | 194 | 65 | 4 | 68705a6eca947c5b42b943d5224a7aef2a744007 | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|IPF / Disease state, Lineage and Cell class | 1.85e-04 | 194 | 65 | 4 | 169a304d5c13f08c39fad4116f093bc4a0765e9d | |
| ToppCell | IPF-Endothelial|IPF / Disease state, Lineage and Cell class | 1.85e-04 | 194 | 65 | 4 | 9591993aa2dcba3d09a0f1ea8b8f2439c26482d6 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-04 | 194 | 65 | 4 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-04 | 194 | 65 | 4 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|COPD / Disease state, Lineage and Cell class | 1.85e-04 | 194 | 65 | 4 | 18b7f901c12ca4f21f9a1eafd092aefe4d668b6d | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-04 | 194 | 65 | 4 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.85e-04 | 194 | 65 | 4 | 55b97095a7a17a312c616703d291738a0f806339 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 1.88e-04 | 195 | 65 | 4 | 120296531bbc8080dcabacbd64733cc1dc34603a | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.88e-04 | 195 | 65 | 4 | 56efeb58df19f357d7d5ce87348d4f196a595421 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|IPF / Disease state, Lineage and Cell class | 1.88e-04 | 195 | 65 | 4 | 2c3ad3cb79f11119ac69c413a938d21199145040 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.88e-04 | 195 | 65 | 4 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_capillary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-04 | 196 | 65 | 4 | f0b106078212be1d0938f545707a004a1e830857 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.92e-04 | 196 | 65 | 4 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-04 | 196 | 65 | 4 | b15812354128c12a588d79ef449d787e74835f3b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-04 | 196 | 65 | 4 | b8f89a50114932c08fc5daac4b549adfe9df8e66 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.92e-04 | 196 | 65 | 4 | 686533fd3fba8e4df96b9dd1307e870e89db4332 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-04 | 196 | 65 | 4 | 145fcf73deba9638b391a1af6c39fa205dc9829f | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 1.92e-04 | 196 | 65 | 4 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-04 | 196 | 65 | 4 | d0ff1082898d2db47c88d2678466514e9e9193d3 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-04 | 197 | 65 | 4 | 78bc83cd5546c7dd128e6791acda97f55089bc1c | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 1.96e-04 | 197 | 65 | 4 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | nucseq-Endothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.96e-04 | 197 | 65 | 4 | ebf9be068eaa658493fa7884fd19f34642922acb | |
| ToppCell | ASK452-Endothelial-Endothelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.00e-04 | 198 | 65 | 4 | e282769f5fa1765bcce79a0ed9d761bf2e14b012 | |
| Drug | Acacetin [480-44-4]; Down 200; 14uM; MCF7; HT_HG-U133A | 1.66e-05 | 192 | 64 | 6 | 6044_DN | |
| Drug | Azaguanine-8 [134-58-7]; Down 200; 26.2uM; MCF7; HT_HG-U133A | 1.81e-05 | 195 | 64 | 6 | 7444_DN | |
| Drug | Hydralazine hydrochloride [304-20-1]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 1.81e-05 | 195 | 64 | 6 | 4746_UP | |
| Drug | Merbromin [129-16-8]; Up 200; 5uM; PC3; HT_HG-U133A | 1.87e-05 | 196 | 64 | 6 | 3700_UP | |
| Drug | Glibenclamide [10238-21-8]; Up 200; 8uM; MCF7; HT_HG-U133A | 1.98e-05 | 198 | 64 | 6 | 3163_UP | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HG-U133A | 2.03e-05 | 199 | 64 | 6 | 122_DN | |
| Drug | Folinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 2.03e-05 | 199 | 64 | 6 | 4725_DN | |
| Disease | invasive ductal carcinoma (is_implicated_in) | 2.59e-04 | 11 | 65 | 2 | DOID:3008 (is_implicated_in) | |
| Disease | glycodeoxycholate measurement | 4.27e-04 | 14 | 65 | 2 | EFO_0010493 | |
| Disease | nasopharynx carcinoma (is_implicated_in) | 4.93e-04 | 15 | 65 | 2 | DOID:9261 (is_implicated_in) | |
| Disease | T-Cell Lymphoma | 5.62e-04 | 16 | 65 | 2 | C0079772 | |
| Disease | lung cancer (is_implicated_in) | 5.91e-04 | 74 | 65 | 3 | DOID:1324 (is_implicated_in) | |
| Disease | urinary albumin to creatinine ratio | 6.64e-04 | 179 | 65 | 4 | EFO_0007778 | |
| Disease | Abnormality of refraction | 6.89e-04 | 673 | 65 | 7 | HP_0000539 | |
| Disease | Epilepsy, Cryptogenic | 7.98e-04 | 82 | 65 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 7.98e-04 | 82 | 65 | 3 | C0751111 | |
| Disease | Aura | 7.98e-04 | 82 | 65 | 3 | C0236018 | |
| Disease | anti-Mullerian hormone measurement | 8.85e-04 | 20 | 65 | 2 | EFO_0004769 | |
| Disease | influenza A (H1N1) | 9.48e-04 | 87 | 65 | 3 | EFO_1001488 | |
| Disease | platelet crit | 1.13e-03 | 952 | 65 | 8 | EFO_0007985 | |
| Disease | obsolete Mendelian syndromes with cleft lip/palate | 1.17e-03 | 23 | 65 | 2 | MONDO_0015335 | |
| Disease | lymphocyte count | ALMS1 BCL2L11 TTC28 PHF19 UBE4B CDK13 PHLPP1 PEX13 ARRDC2 MEX3B | 1.30e-03 | 1464 | 65 | 10 | EFO_0004587 |
| Disease | alpha-linolenic acid measurement | 1.39e-03 | 25 | 65 | 2 | EFO_0007759 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 1.50e-03 | 26 | 65 | 2 | DOID:234 (is_implicated_in) | |
| Disease | Hodgkins lymphoma, multiple myeloma, non-Hodgkins lymphoma | 1.74e-03 | 28 | 65 | 2 | EFO_0000183, EFO_0001378, EFO_0005952 | |
| Disease | Epilepsy | 1.81e-03 | 109 | 65 | 3 | C0014544 | |
| Disease | opioid dependence | 1.87e-03 | 237 | 65 | 4 | EFO_0005611 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FSGNTALETAYSSTN | 2216 | Q96PZ7 | |
| YSRSRGSPSSYNSSS | 176 | Q9H201 | |
| ASSSSYSNREKASIF | 1891 | Q8TCU4 | |
| NGYASSSLSIDSRSS | 111 | Q8TAB5 | |
| SSLLSRSSSGYFSFD | 86 | O43521 | |
| SDNNSSSRGDASYNS | 481 | Q9NZW4 | |
| SDSYSSRTSSQSKGN | 656 | Q9UHI6 | |
| TTSSSATSGSNYQRD | 26 | A6NGY3 | |
| STSDYKDNFGSSSFS | 1331 | Q14004 | |
| ESRSAGSSTAYTQSY | 61 | Q8TBH0 | |
| SYSSSRSDLYSSGRD | 326 | P38159 | |
| NSFYGSSSLTNSSQS | 521 | Q8TB72 | |
| AKYRSASSTSSLFSS | 671 | Q8TB72 | |
| DYRQSSGASSSSFSS | 601 | O00571 | |
| GKNASTSATSRSYSS | 176 | Q9ULC0 | |
| SSSSSYTNYADSVKG | 71 | P01762 | |
| LSNFSTSDNGSYSSN | 151 | P46934 | |
| SSSLQASTTNDSGYR | 686 | Q8IWI9 | |
| DSFRSYNSSVGSESS | 31 | Q969R5 | |
| SARSYSTESYGASQT | 1201 | Q96NW7 | |
| SSLYSGSAQSSRSNS | 301 | Q6UXY1 | |
| LFSGDFSASTYSNSV | 4421 | Q5CZC0 | |
| ASLFSTYASAEADSS | 621 | P13535 | |
| KSSRDSLQYSSGYST | 461 | Q765P7 | |
| SLSPGAFSYSSSSRF | 26 | P41219 | |
| AFSYSSSSRFSSSRL | 31 | P41219 | |
| SSADLSSLSGFNTAS | 326 | Q06413 | |
| LSSSSGGSSSFDRFA | 261 | Q8NGI8 | |
| RTSSGDFKFSSSYSA | 766 | Q6ZMV5 | |
| STGNSLTFHFYSDSS | 1936 | O60494 | |
| SSSTSSQAHYRLSAF | 91 | Q9P2N4 | |
| YSDGSSSILSTNNAT | 61 | P07333 | |
| FYSRAASSTSQSGLS | 351 | Q9BYI3 | |
| KQFTSSTSYNRGDST | 581 | P02671 | |
| STSYNRGDSTFESKS | 586 | P02671 | |
| TESLYSFDSRRSSGF | 786 | Q9Y4D2 | |
| ASSYSFSDLNSTRGD | 56 | P50402 | |
| SYQGSGKSLTFSDTS | 936 | Q13255 | |
| ANSSFYSTRSAPASQ | 1831 | Q14980 | |
| FSSYRNDSSSSLGSA | 281 | Q6ZN04 | |
| NDSSSSLGSASTDSY | 286 | Q6ZN04 | |
| SAFSSFDFSYSGAER | 541 | A2RUB1 | |
| SADTGQYASTSASSS | 341 | Q02446 | |
| YPSSRDSYSSSSRGA | 356 | Q96E39 | |
| SSSTFSFSGRDSSFT | 226 | O95425 | |
| FNSRGFEDSYATDSS | 311 | Q17RD7 | |
| GDASYTASAIRSSTY | 301 | P22670 | |
| RDSAYSSFSASSNAS | 186 | Q9ULL8 | |
| VASNFTFGASSSSAR | 96 | O15457 | |
| SSVNTFRPAYSSFSS | 66 | Q92968 | |
| RDAYGTSSLSSSSNS | 26 | O15079 | |
| AYSSDRSGTSNSQSQ | 376 | O00444 | |
| DSVFSSAATSSNAYT | 381 | P52594 | |
| SLSGTSYSFSSLENT | 651 | G9CGD6 | |
| AGASAASYSSTQFDS | 326 | Q86W33 | |
| ASFGASSLSSLYESS | 261 | O95155 | |
| SSLSGVENLNSSYFS | 246 | Q99592 | |
| QSRSYSSADSYSSTR | 596 | A7MD48 | |
| ARGSYSSIVNSSSSS | 1616 | Q92545 | |
| SAFSTRSDASGTNDF | 1371 | Q92626 | |
| AASTSGSASTSLSYD | 451 | Q5T6S3 | |
| ESSSASASSYYSQDD | 31 | Q9UBS9 | |
| SGYLSVLASSTFAAS | 46 | A1L157 | |
| LLYSSSQDGFLSSST | 16 | Q6ZVL8 | |
| VGSYSSAAFNSTRDF | 86 | Q15915 | |
| SPALSYSSAGSARSS | 2321 | Q96AY4 | |
| YAAATLQASSAASSA | 211 | P18887 | |
| SLSSSGSYSLQATNE | 141 | Q6S9Z5 | |
| LSSATFSSAFSDNGL | 1531 | O60346 | |
| GNSNSSSSRLSQYFE | 301 | Q6BDS2 | |
| DDSRSYASSFSGYST | 66 | Q9ULE0 | |
| ASNASSYLTSASSLA | 1771 | O95071 | |
| FDSSGSFLSYINTSA | 696 | O75382 |